Sri Krishna Pharmaceuticals
India
Hybrid — also manufactures internal programs
Program data pending ClinicalTrials.gov matching
Profiled
Not yet scored
✓ FDA Inspections (4)
○ Clinical Trials
○ SEC Filings
○ Press
○ EMA GMP
○ MHRA GMP
✓ HC GMP (13)
Quick Facts: Sri Krishna Pharmaceuticals
- Signal Score
- Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
- Headquarters
- India
- Website
- https://www.srikrishnapharma.com/
- Modalities
- Small Molecule API, Oral Solid Dose
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
About Sri Krishna Pharmaceuticals
Sri Krishna Pharmaceuticals makes its own pharmaceutical products and also offers contract development and manufacturing services. Capabilities: Small Molecule API, Oral Solid Dose. 3 manufacturing sites registered with the U.S. FDA and Health Canada. Website: https://www.srikrishnapharma.com/
Signal Score
Profiled, not yet scored.
Scores are published after regulatory evidence is attached and reviewed.
How scoring works
Sri Krishna Pharmaceuticals FDA Inspection History
2025-06
2025-04
2023-09
2023-05
NAI
VAI
OAI
| Date | Site | Type | Observations | Classification |
|---|---|---|---|---|
| 2025-06-27 |
Sri Krishna Pharmaceuticals Limited
Hyderabad
Company-level
|
Drug Quality Assurance | Yes | Official Action Indicated (OAI) |
| 2025-04-18 |
SRI Krishna Pharmaceuticals Ltd
Hyderabad
Company-level
|
Drug Quality Assurance | No | Voluntary Action Indicated (VAI) |
| 2023-09-01 |
SRI Krishna Pharmaceuticals Ltd
Hyderabad
Company-level
|
Drug Quality Assurance | No | Official Action Indicated (OAI) |
| 2023-05-19 |
Sri Krishna Pharmaceuticals Limited
Hyderabad
Company-level
|
Drug Quality Assurance | Yes | Official Action Indicated (OAI) |
Source: FDA Data Dashboard · Retrieved Oct 31, 2026
Sri Krishna Pharmaceuticals FDA 483 Findings 16 observations · 2023-05-19 → 2025-06-27 ?
By subsystem
By severity
- 5 — Critical: 1
- 3 — Moderate: 4
- 2 — Minor: 11
- Repeat observations: 4
Most severe findings
-
Computer control of master formula records
"Appropriate controls are not exercised over computers or related systems to assure that changes in master production and control records or other records are instituted only by authorized personnel."
-
Extent of discrepancy, failure investigations
"Investigations of an unexplained discrepancy did not extend to other drug products that may have been associated with the specific failure or discrepancy."
-
Complaint Investigation/Follow-Up Findings
"Complaint records are deficient in that they do not include the findings of the investigation and follow-up."
Hiring Activity Beta
Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source:
public careers pages
· Checked Oct 30, 2026
Frequently Asked Questions About Sri Krishna Pharmaceuticals
How many FDA inspections does Sri Krishna Pharmaceuticals have on record?
CDMO Signal tracks 4 FDA inspections for Sri Krishna Pharmaceuticals, sourced from the FDA inspection database. See the full inspection history above.
Has Sri Krishna Pharmaceuticals received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Sri Krishna Pharmaceuticals.
Does Sri Krishna Pharmaceuticals have a CDMO Signal Score?
Not yet. Sri Krishna Pharmaceuticals is profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed.
Evaluating Sri Krishna Pharmaceuticals for a manufacturing program?
Use the free AI matchmaker to compare Sri Krishna Pharmaceuticals against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
Similar CDMOs
Shilpa Medicare
India (registered sites)
Small Molecule API, Oral Solid Dose, Sterile Fill-Finish, Biologics, Peptides & Oligos
Aarti Drugs
India
Small Molecule API, Oral Solid Dose
MSN Laboratories
India
Small Molecule API, Oral Solid Dose
Indoco Remedies
Mumbai, India
Small Molecule API, Intermediates, Custom Synthesis, Oral Solid Dose, Topicals
BDR Pharmaceuticals
Mumbai, India
Oncology Products, Oral Solid Dose, Sterile Injectables, Small Molecule API
Compare Sri Krishna Pharmaceuticals with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.